This join laboratory named Inserm-RIKEN Lipidomics Unit (IRLU) aims at developing nanoscale imagery of lipid structures to study their influence on cellular mechanisms and to better understand disease such as diabetes.

The 2-year renewable agreement will facilitate technological infrastructures share and cooperation. Research will be carried out both in France at INSA Lyon and in Tokyo at Riken Sphingolipid Functions and Lipid Biology labs.